Skip to content

The University of Texas at ArlingtonThe University of Texas at Arlington

College of Science

ACES – 2018 Research Symposium

ACES – 2018 Research Symposium - College of Science

College of Science ACES – 2018 Research Symposium

Friday, April 13, 2018
8 a.m. to 6 p.m.
Chemistry & Physics Building (CPB)
Atrium and Planetarium

The ACES symposium has a long-standing history at UTA as a place for students to showcase their research accomplishments. Historically, this has been a University-wide event, but this year, each of the colleges is organizing their own events. Join us for the inaugural College of Science ACES! All College of Science undergraduate and graduate students are eligible to participate. The event is open to the public. 

Online abstract submissions are due by Friday, March 9. Space for submissions may be limited, so don’t wait until the last minute!

Student/Team Abstract Submissions

Guests who wish to attend are asked to RSVP at the link below (participants must submit abstracts but do not need to RSVP).


Judges are needed! To volunteer to serve as a judge, please send an email to Alejandro Bugarin, assistant professor of chemistry & biochemistry, at

COS ACES will be primarily based on poster presentations, but each department will select one graduate feature oral presentation. Prizes will be awarded for best presentations. Final winners will be chosen by an audience ballot, so students in each department are encouraged to come and support their peers!

Would you like to support the College of Science ACES symposium?


Keynote Presentation

Tracy Ryan,
CEO of CannaKids, CK Sciences and founder of

“From Diagnosis to Discovery: A Cancer Mom’s Journey to Save The Sick”

Cannabis medicine has come a long way, giving patients numerous options to augment or even replace certain pharmaceutical regimens. This presentation will help the audience understand the basics cannabis medicine and the importance of individualized dosing protocols. We will examine anecdotal findings on the use of medical cannabis in pediatric and adult diseases while evaluating various patient success stories. Furthermore, as the cannabis marketplace erupts, we will discuss what new discoveries have been made, what human trials are to come and what the projected evolution of medical cannabis looks like.

Corporate Sponsors